Efficacy News and Research

RSS
NeuroSigma's Monarch eTNS System to make Canadian debut at 30th International Epilepsy Congress

NeuroSigma's Monarch eTNS System to make Canadian debut at 30th International Epilepsy Congress

Clinical study shows that clopidogrel not effective in infants with congenital heart diseases

Clinical study shows that clopidogrel not effective in infants with congenital heart diseases

TSRI scientists find dual inhibitor that attacks two enzymes associated with Parkinson's disease

TSRI scientists find dual inhibitor that attacks two enzymes associated with Parkinson's disease

Medicago produces Rotavirus VLP vaccine candidate using plant-based manufacturing platform

Medicago produces Rotavirus VLP vaccine candidate using plant-based manufacturing platform

CLOTS 3 trial demonstrates efficacy of Covidien's Kendall SCD system on immobile stroke patients

CLOTS 3 trial demonstrates efficacy of Covidien's Kendall SCD system on immobile stroke patients

EORTC starts phase 2 trial in elderly patients with HER-2 positive metastatic breast cancer

EORTC starts phase 2 trial in elderly patients with HER-2 positive metastatic breast cancer

Treating bacteria with silver compounds boosts efficacy of old antibiotics

Treating bacteria with silver compounds boosts efficacy of old antibiotics

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Bristol-Myers Squibb and AstraZeneca announce top line results of Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza

Moscamed introduces new programme to control dengue mosquitoes in Jacobina

Moscamed introduces new programme to control dengue mosquitoes in Jacobina

Results of ibrutinib Phase 2 study in patients with mantle cell lymphoma published in NEJM

Results of ibrutinib Phase 2 study in patients with mantle cell lymphoma published in NEJM

Staph-killing compound may be effective against osteomyelitis

Staph-killing compound may be effective against osteomyelitis

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Safinamide improves responder rates in fluctuating Parkinson's patients in Phase III study

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

Ico Therapeutics completes Phase 2 iDEAL study for treatment of diabetic macular edema

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

OHSU analysis finds previous studies have overstated effectiveness of bone growth product used in spinal surgeries

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

NIH awards $12.7M to research groups to explore new treatments for patients in eight disease areas

UHCMC physicians design new procedure to clear blocked carotid arteries, prevent stroke

UHCMC physicians design new procedure to clear blocked carotid arteries, prevent stroke

Eylea can ease vision problems for wet AMD patients

Eylea can ease vision problems for wet AMD patients

OncoSec Medical completes enrollment in ImmunoPulse trial for metastatic melanoma patients

OncoSec Medical completes enrollment in ImmunoPulse trial for metastatic melanoma patients

Bioapplications of nanoparticles: an interview with Dr Catherine Berry, University of Glasgow

Bioapplications of nanoparticles: an interview with Dr Catherine Berry, University of Glasgow

AtriCure's Bipolar RF Ablation System shows promising results in persistent Afib patients

AtriCure's Bipolar RF Ablation System shows promising results in persistent Afib patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.